Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Return on Equity (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Return on Equity for 15 consecutive years, with 0.17% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity fell 12.0% year-over-year to 0.17%, compared with a TTM value of 0.17% through Sep 2025, down 12.0%, and an annual FY2024 reading of 0.02%, up 47.0% over the prior year.
  • Return on Equity was 0.17% for Q3 2025 at Rockwell Medical, down from 0.07% in the prior quarter.
  • Across five years, Return on Equity topped out at 28.25% in Q1 2022 and bottomed at 4.79% in Q4 2021.
  • Average Return on Equity over 5 years is 0.44%, with a median of 0.61% recorded in 2023.
  • The sharpest move saw Return on Equity soared 2923bps in 2022, then crashed -2924bps in 2023.
  • Year by year, Return on Equity stood at 4.79% in 2021, then skyrocketed by 74bps to 1.24% in 2022, then surged by 67bps to 0.41% in 2023, then skyrocketed by 96bps to 0.02% in 2024, then plummeted by -845bps to 0.17% in 2025.
  • Business Quant data shows Return on Equity for RMTI at 0.17% in Q3 2025, 0.07% in Q2 2025, and 0.01% in Q1 2025.